Ocean Biomedical OCEA Cash Flow Statement (2021-2025)

OTC OCEA
$0.00 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Ocean Biomedical Quarterly Cash Flow Statement

Periods 14 quarters
Latest Mar 2025

Ocean Biomedical reported cash from operations of -$0.36M and free cash flow of -$0.36M for the quarter ended Mar 2025, up 26.6% year over year. This cash flow statement covers 14 quarters of results from Dec 2021 through Mar 2025, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025
Operating Activities
Net Income -5.38M-7.33M-3.67M-0.98M-72.09M-11.43M-14.09M-16.86M13.00M-17.23M-3.70M-1.54M-8.24M
Share-based CompensationStock Comp. 4.54M4.90M2.93M0.65M0.19M0.19M0.19M0.19M0.19M0.19M0.19M0.19M
Gains from Investment SecuritiesGains Investment -1.16M0.57M1.76M-1.01M-0.33M-0.04M-0.09M0.27M
Other non-cash itemsOther Non-Cash 0.02M0.37M0.44M0.36M15.14M2.32M0.22M-0.04M2.61M
Change in Working Capital
Change in Account PayablesChange Payables 0.03M0.08M0.04M0.48M-0.16M0.04M0.11M-0.03M0.00M-0.25M-0.06M0.03M
Change in Accured ExpensesChange Accured Exp. -1.00M3.35M-0.14M0.60M1.61M-1.11M1.54M-0.81M0.77M0.54M0.24M-0.67M0.85M
Change in Other Operating AssetsOther Assets Change -0.12M-0.18M-0.04M0.18M-0.23M-0.25M-0.22M0.13M
Other Working Capital ChangesOther WC Changes 0.12M0.18M0.04M-0.18M0.23M0.25M0.22M-0.13M
Cash from OperationsCash from Ops. -0.37M-0.15M-0.44M-0.03M-2.65M-4.78M-1.13M-0.87M-0.49M-0.29M-0.96M-2.45M-0.36M
Financing Activities
Debt Issuance and Repayment
Short-Term Debt issuancesST Debt Issuance 0.60M0.17M0.03M-0.05M1.43M6.74M0.09M0.91M
Short-Term Debt repaymentsST Debt Repayment 0.55M1.55M
Current Debt 0.60M0.17M0.03M-0.05M0.88M5.19M0.09M0.91M
Net Debt Issuances and RepaymentsNet Debt Issuance 0.60M0.17M0.03M-0.05M0.88M5.19M0.09M0.91M
Change in Capital Stock
Common Stock IssuedStock Issued 14.26M0.06M
Net Shares Issued and RepurchasedNet Shares Issued 14.26M0.06M
Net Equity Issued and RepurchasedNet Equity Issued 14.26M0.06M
Other financing activitiesOther financing -0.04M-0.17M-12.68M
Cash from Financing ActivitiesCash from Financing 0.60M0.26M0.16M-0.05M2.92M6.64M0.84M-51.10M2.43M0.91M
Additional items
Change in Cash 0.23M0.10M-0.28M-0.08M0.27M1.86M-1.13M-0.03M-0.49M-0.29M0.01M-0.02M0.55M
Ending Cash Balance 0.06M0.29M0.40M0.12M0.03M0.31M2.16M1.03M1.00M0.52M0.23M0.24M0.22M0.80M
Free Cash FlowFCF -0.37M-0.15M-0.44M-0.03M-2.65M-4.78M-1.13M-0.87M-0.49M-0.29M-0.96M-2.45M-0.36M
Net Cash FlowNCF 0.23M0.10M-0.28M-0.08M0.27M1.86M-1.13M-0.03M-0.49M-0.29M-52.06M-0.02M0.55M

Ocean Biomedical Cash Flow Statement API

Pull Ocean Biomedical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=OCEA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY